Given the ongoing integration of the global pharmaceutical market, drug and medical device manufacturers are subject to inspections by GMP authorities from different countries. Whether foreign companies entering the Chinese market or domestic companies expanding internationally, all face significant challenges in responding to on-site inspections within unfamiliar regulatory systems. Companies often lack adequate preparation due to unfamiliarity with target market regulations, regulatory and cultural differences, language barriers, inspection processes, and inexperience - leading to inspection failures and even affect product launch timelines and corporate reputation.
International Team
Experts with backgrounds in China, Europe, and the U.S., capable of accurately interpreting and translating requirements across different regulatory systems.
Customized Services
We offer tailored service packages ranging from "fast check-up" to "in-depth improvement" based on urgency due to an inspection and client readiness, meeting individual needs.
20+ Years Practical Experience
Over 20 years of GMP service experience, including direct participation with clients in various official inspections.
Combining efficiency with cost
We provides risk-based and resource-appropriate response strategies, avoiding unnecessary large-scale adjustments and focusing on key regulatory priorities to achieve maximum inspection readiness in the shortest possible time.
Full Support
We deliver hands-on guidance throughout the entire process - from training and mock inspections to corrective action tracking and deficiency response - to ensure thorough preparation.